Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.

Min Jeong WangSangHak YiJee-Young HanSo Young ParkJae-Won JangIn Kook ChunSang Eun KimByoung Sub LeeGwang Je KimJi Sun YuKuntaek LimSung Min KangYoung Ho ParkYoung Chul YounSeong Soo A AnSang Yun Kim

Published in: Alzheimer's research & therapy (2017)

Plasma levels of Aβ oligomers could be assessed using MDS, which might be a simple, noninvasive, and accessible assay for evaluating brain amyloid deposition related to AD pathology.

Keyphrases

resting state
white matter
high throughput
cognitive decline
protein protein
amino acid
human health
functional connectivity
binding protein
risk assessment
brain injury
climate change
subarachnoid hemorrhage